When a premature newborn is showing signs of developing respiratory distress syndrome or bronchopulmonary dysplasia, which of the following treatments is most likely given to reduce the chance of the infant having these problems?

Question

Quizplus · Accepted Answer

Exogenous surfactant therapy is used to treat or prevent respiratory distress syndrome in premature infants by reducing the surface tension in the lungs, thus improving lung function and reducing the risk of bronchopulmonary dysplasia.

When a Premature Newborn Is Showing Signs of Developing Respiratory